First aim: PARIS study The main aim of the current study is to determine the association between abdominal aortic aneurysm (AAA) progression and the evolution of proteases and cytokines levels.To achieve this aim, we will prospectively collect blood, aortic tissue, patient data, and imaging data. Aortic tissue will only be obtained when patients undergo conventional open repair. The other biomaterials will be collected during regular patient follow-up visits, with a maximum frequency of once per year. Second aim: Pearl AAA biobank For future research purposes, a new biobanking infrastructure will be created to collect and store additional blood and urine samples in a biobank. This biobank will be embedded within the infrastructure of the 'Parelsnoer Institute' (PSI) and will be called Pearl AAA. The Pearl AAA will be established in the extension of the PARIS study
The PARIS study aims to determine the correlation between AAA progression (growth or rupture) and the evolution of serum levels of proteases and cytokines over time. A repeated measures analysis will be done to use all longitudinal data available. The Pearl AAA biobank will be established to enable the PARIS study, but also aims to facilitate future research. Such future research should fall under the scientific aims of the Pearl AAA, which are: * To gain insight in the pathogenesis of AAA * To gain more knowledge in the rupture risk of AAA * To evaluate and potentially improve treatment of AAA The 'Parelsnoer Institute' will facilitate the biobank Pearl AAA with certain aspects such as, but not limited to the following: * Standardized operating procedures for the collection and storage of the biosamples across all participating hospitals * Information architect to establish a data dictionary in which all variables are defined * Standardized procedures for coding of patient data before storage * Standardized digital infrastructure to enhance storage of patient data and imaging data
Study Type
OBSERVATIONAL
Enrollment
790
Leiden University Medical Center (LUMC)
Leiden, South Holland, Netherlands
Department of Vascular Surgery, Amsterdam UMC, location AMC
Amsterdam, Netherlands
AAA growth
Growth of abdominal aortic aneurysm, measured on imaging made for clinical purposes
Time frame: Up to 10 years of follow-up
AAA rupture
Rupture of an abdominal aortic aneurysm
Time frame: Up to 10 years of follow-up
Death
All-cause mortality
Time frame: Up to 10 years of follow-up
Evolution of serum levels of proteases
Repeated measurements analysis of serum levels of proteases in cohort of asymptomatic AAAs
Time frame: a maximum of 1 measurement annually up to 10 years of follow-up
Evolution of serum levels of cytokines
Repeated measurements analysis of serum levels of cytokines in cohort of asymptomatic AAAs
Time frame: a maximum of 1 measurement annually up to 10 years of follow-up
Protease levels in aortic tissue
Protease levels in aortic tissue
Time frame: If open AAA repair is performed and aortic tissue is collected, protease levels will then be measured. This is a one-time measurement.
Cytokine levels in aortic tissue
Cytokine levels in aortic tissue
Time frame: If open AAA repair is performed and aortic tissue is collected, cytokine levels will then be measured. This is a one-time measurement.
Type of complications after AAA repair
Type of complications using methodology from the Dutch committee of the "Nederlandse Vereniging voor Heelkunde," named the "Landelijke Heelkunde Complicatie Registratie" as found on www.lhcr.nl
Time frame: Will be measured up to 10 years after AAA repair is performed
Incidence of complications after AAA repair
Number of complications after abdominal aortic aneurysm repair
Time frame: Will be measured up to 10 years after AAA repair is performed
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.